Passion to Performance
Changing the lives of cancer patients

Incendia Therapeutics strives to provide a professional employee-friendly environment in which goal-oriented individuals thrive in meeting the challenges of our vision.

Job Opportunities

We are a young, driven company with the passion to advance the understanding of cancer immune exclusion and resistance in a way that leads to therapies intended to make a meaningful change in the lives of cancer patients.

View Job Listing

Learn more about our Statement About Fraud

Culture and Values

Our Mission

Incendia Therapeutics was created to serve cancer patients who are in need of novel therapeutics. Everything we do here is guided by caring for and doing the right thing for those patients.

Our Values

Incendia’s core values – tenacity, rigor, and innovation – are shaped by our team, which is fighting cancer through novel discoveries, hard work, and a rigorous approach to the science. Our values support our mission, just as our team members support each other.

Kendra photo

Employee Spotlight

“At Incendia, I’ve been able to play an integral role in critical tumor biology research. With the skills of our scientists and the speed we’ve been able move towards the clinic, I can’t wait to see the impact made for patients this year.”

Kendra Ouellette
Associate Scientist II, Tumor Biology

Thomas photo

Employee Spotlight

“At Incendia, it’s not about what you achieve as an individual. It’s about what you achieve as part of the team. That’s why we don’t have big egos here.”

Thomas Schürpf, PhD
VP, Head of Development

Joshua photo

Employee Spotlight

“At Incendia I’ve been allowed the space and encouraged to go beyond what is merely described in my role. As such, I’ve increased my skills at conceptualizing and anticipating the scientific needs of the project and designing experiments that address them. I’m very happy to have the opportunity to develop these skills, because they get me closer to fulfilling the vision I have of becoming a well-rounded scientific leader.”

Joshua Merritt
Senior Associate Scientist